SHOview Observational Study. Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.

Trial Profile

SHOview Observational Study. Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2014

At a glance

  • Drugs Menotropin (Primary)
  • Indications Female infertility
  • Focus Adverse reactions
  • Acronyms SHOview
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jun 2014.
    • 10 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top